Attovia Therapeutics, Inc. - 10-Q Filing
Attovia Therapeutics, Inc. reports Q3 financial results including collaboration revenue and ongoing R&D expenditures.
Tickers: $ATTO
Attovia Therapeutics, Inc. reports Q3 financial results including collaboration revenue and ongoing R&D expenditures.
Tickers: $ATTO